UNITED STATES SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549  FORM
10  Q (Mark One) x**QUARTERLY REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** For the quarterly period endedDecember
31, 2009  or  oTRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the transition period from
____________ to ________________  Commission file number:
333-139669  CYTTA CORP.(Exact name of Registrant as specified
in its charter)Nevada

98-0505761(State or other jurisdiction of
incorporation or organization)

(IRS Employer Identification
No.)905 Ventura Way, Mill Valley, CA
 94941(Address of principal executive
offices)(415) 860-5192(Registrants telephone number,
including area code)  Indicate by check mark
whether the Registrant (1) has filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the Registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days.  Yes x  No o  Indicate by check mark
whether the registrant has submitted electronically and posted on its corporate
Web site, if any, every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the registrant was
required to submit and post such files). Yes o  No
o  Indicate by check mark
whether the Registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated filer, and smaller reporting company
in Rule 12b-2 of the Exchange Act (Check one).   Large accelerated filer o

Accelerated filer oNon-accelerated filer o

Smaller reporting company x(Do not check if a smaller reporting
company)  Indicate by check mark
whether the Registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No x  As of February 10, 2010,
there were 605,400,000 shares of the issuers common stock, par value $0.00001,
outstanding.   PART I  FINANCIAL INFORMATION ITEM
1. FINANCIAL
STATEMENTS The
accompanying unaudited financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of America
and the rules of the Securities and Exchange Commission ("SEC"), and should be
read in conjunction with the audited financial statements and notes thereto
contained in the Company's September 30, 2009 Form 10-K filed with the SEC on
January 13, 2010. In the opinion of management, all adjustments, consisting of
normal recurring adjustments, necessary for a fair presentation of financial
position and the results of operations for the periods presented have been
reflected herein. The results of operations for the periods presented are not
necessarily indicative of the results to be expected for the full year.  2         CYTTA
CORP. (A
Development Stage Company)  INTERIM FINANCIAL STATEMENTS  DECEMBER 31, 2009  (Unaudited)      Page  Balance
Sheets as of December 31, 2009 (unaudited) and September 30, 2009 4  Interim Statements of
Operations for the three months ended December 31, 2009 and 2008 (unaudited) and
for the Period from May 30, 2006 (inception) through December 31, 2009
(unaudited)  5  Interim Statements of
Cash Flows for the three months ended December 31, 2009 and 2008 (unaudited) and
for the Period from May 30, 2006 (inception) through December 31, 2009
(unaudited)  6  Notes
to Interim Financial Statements (unaudited) 7  3    Cytta Corp. (A Development Stage Company) Balance Sheets     ASSETSAs
of


As ofDecember
31,


September
30,2009


2009(Unaudited)CURRENT ASSETSCash and cash
equivalents
$
136

$
136TOTAL ASSETS
$
136

$
136LIABILITIES
AND STOCKHOLDERS DEFICITCURRENT
LIABILITIESAccounts payable and accrued
liabilities
$
9,489

$
18,052Due to
related party (Note 5)

21,414


9,388TOTAL LIABILITIES

30,903


27,440STOCKHOLDERS'
DEFICITCapital
Stock (Note 3)Authorized:100,000,000
preferred shares, $0.001 par value1,900,000,000
common shares, $0.00001 par valueIssued and outstanding
shares:605,400,000
common shares

6,054


6,054Additional paid-in capital

199,456


199,45656,000,000 common shares
pending cancellation

560


560Deficit accumulated during the
development stage

(236,837)


(233,374)Total Stockholders'
Deficit

(30,767)


(27,304)TOTAL LIABILITIES AND
STOCKHOLDERS' DEFICIT
$
136

$
136    -The accompanying notes
are an integral part of these financial statements  4


Cytta Corp. (A Development Stage Company) Interim Statements of Operations (Unaudited)    Cumulative
fromInception(May 30, 2006)
toThree Months Ended
December 31,


December
31,2009


2008


2009REVENUES







$
-

$
-

$
-OPERATING EXPENSESProfessional fees








3,295


13,942


84,564General and
administrative








168


11,368


35,692Impairment of licensing
agreement








-


-


116,581Total Operating
Expenses








3,463


25,310


236,837Other Income
(Expense)








-


-


-Provision
for Income Taxes(Note
4)








-


-


-Net Loss







$
(3,463)

$
(25,310)

$
(236,837)PER SHARE DATA:Basic and diluted loss percommon share







$
(0.00)

$
(0.00)Weighted average number
ofcommon shares
outstanding








605,400,000


484,000,000   -The accompanying notes
are an integral part of these financial statements -


5


Cytta Corp. (A Development Stage Company) Interim Statements of Cash Flows (Unaudited)   Cumulative fromInception(May 30, 2006) toThree Months Ended December 31,

December 31,2009


2008

2009OPERATING
ACTIVITIESNet
loss
$
(3,463)

$
(25,310)

$
(236,837)Adjustments to reconcile net loss to net cash
used in operations:Amortization and depreciation

-


-


3,419Impairment of licensing agreement

-


-


116,581Issuance of common stock for consulting
services

-


-


70Changes
in Operating Assets and Liabilities:Increase
(decrease) in accounts payable and accrued liabilities

(8,563)


(6,158)


9,489Net
Cash Used in Operating Activities

(12,026)


(31,468)


(107,278)FINANCING
ACTIVITIESIssuance
of capital stock

-


-


86,000Advances
from a related party

12,026


-


21,414Net
Cash Provided by Financing Activities

12,026


-


107,414NET
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-


(31,468)


136CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

136


34,536


-CASH
AND CASH EQUIVALENTS AT END OF PERIOD
$
136

$
3,068

$
136Supplemental
Cash Flow Disclosures:Cash
paid for Interest
$
-

$
-

$
-Cash
paid for Income Taxes
$
-

$
-

$
-Non-Cash
Financing and Investing Activities:Common
stock issued for licensing agreement
$
-

$
-

$
120,000   -The accompanying notes
are an integral part of these financial statements -


6


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements December 31, 2009 (Unaudited)    NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS  Cytta
Corp., (the Company) was incorporated on May 30, 2006 under the laws of the
State of Nevada.  It is located in Mill Valley, California.  The
accounting and reporting policies of the Company conform to accounting
principles generally accepted in the United States of America, and the Companys
fiscal year end is September 30. Currently, the Company is a development stage company that intends
to manufacture, distribute and market various telephony based internet access
and computing products and services. To date, the Companys activities have been
limited to its formation and the raising of equity capital.  Development Stage Company  The Company is considered to be in the development stage as
defined in ASC 915-10-05 Development Stage Entity.  NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  Use of Estimates  The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amount of revenues and expenses during
the reporting period.  Actual results could differ from those estimates.
The Companys periodic filings with the Securities and Exchange Commission
include, where applicable, disclosures of estimates, assumptions, uncertainties
and markets that could affect the financial statements and future operations of
the Company. Cash and Cash Equivalents  Cash and cash equivalents include cash in banks, money market
funds, and certificates of term deposits with maturities of less than three
months from inception, which are readily convertible to known amounts of cash
and which, in the opinion of management, are subject to an insignificant risk of
loss in value.  The Company had $136 in cash and cash equivalents at
December 31, 2009 and September 30, 2009.  NOTE
2 - SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES (continued)  Start-Up Costs  In accordance with ASC 720-15-20, Start-up Activities,
the Company expenses all costs incurred in connection with the start-up and
organization of the Company.  Risks and Uncertainties  The
Company operates in the technology industry which is subject to significant
risks and uncertainties, including financial, operational, technological, and
other risks associated with operating a technology business, including the
potential risk of business failure.    7    Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements December 31, 2009 (Unaudited)    NOTE
2 - SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES (continued)  Concentrations of Credit Risk  The
Companys financial instruments that are exposed to concentrations of credit
risk primarily consist of its cash and cash equivalents and related party
payables it will likely incur in the near future.  The Company places its
cash and cash equivalents with financial institutions of high credit worthiness.
 At times, its cash and cash equivalents with a particular financial
institution may exceed any applicable government insurance limits.  The
Companys management plans to assess the financial strength and credit
worthiness of any parties to which it extends funds, and as such, it believes
that any associated credit risk exposures are limited  Earnings (Loss) Per Share of Common Stock  The Company has adopted ASC 260-10-20, Earnings per
Share, (EPS) which requires presentation of basic and diluted EPS on the
face of the income statement for all entities with complex capital structures
and requires a reconciliation of the numerator and denominator of the basic EPS
computation to the numerator and denominator of the diluted EPS computation.
 In the accompanying financial statements, basic earnings (loss) per share
is computed by dividing net income (loss) by the weighted average number of
shares of common stock outstanding during the period.  The Company has no potentially dilutive securities, such as
options or warrants, currently issued and outstanding.  Comprehensive Income (Loss)  ASC Topic No. 220, Comprehensive Income,establishes
standards for reporting and display of comprehensive income and its components
in a full set of general-purpose financial statements.  From inception (May
30, 2006) to December 31, 2009, the Company had no items of other comprehensive
income.  Therefore, net loss equals comprehensive loss from inception (May
30, 2006) to December 31, 2009.  Recent Accounting Pronouncements  In June 2009, the FASB established the Accounting Standards
Codification (Codification or ASC) as the source of authoritative accounting
principles recognized by the FASB to be applied by nongovernmental entities in
the preparation of financial statements in accordance with generally accepted
accounting principles in the United States (GAAP). Rules and interpretive
releases of the Securities and Exchange Commission (SEC) issued under
authority of federal securities laws are also sources of GAAP for SEC
registrants. Existing GAAP was not intended to be changed as a result of the
Codification, and accordingly the change did not impact our financial
statements. The ASC does change the way the guidance is organized and
presented.  Statement of Financial Accounting Standards (SFAS) No. 165 (ASC
Topic 855), Subsequent Events, SFAS No. 166 (ASC Topic 810),
Accounting for Transfers of Financial Assets-an Amendment of FASB Statement
No. 140, SFAS No. 167 (ASC Topic 810), Amendments to FASB
Interpretation No. 46(R), and SFAS No. 168 (ASC Topic 105), The FASB
Accounting Standards Codification and the Hierarchy of Generally Accepted
Accounting Principles- a replacement of FASB    8    Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements December 31, 2009 (Unaudited)   Recent Accounting Pronouncements (continued)  Statement No. 162 were recently issued. SFAS No. 165, 166,
167, and 168 have no current applicability to the Company or their effect on the
financial statements would not have been significant.  Accounting Standards Update (ASU) ASU No. 2009-05 (ASC Topic
820), which amends Fair Value Measurements and Disclosures  Overall, ASU No.
2009-13 (ASC Topic 605), Multiple Deliverable Revenue Arrangements, ASU No.
2009-14 (ASC Topic 985), Certain Revenue Arrangements that include Software
Elements, and various other ASUs No. 2009-2 through ASU No. 2009-15 which
contain technical corrections to existing guidance or affect guidance to
specialized industries or entities were recently issued. These updates have no
current applicability to the Company or their effect on the financial statements
would not have been significant.  NOTE 3 -   CAPITAL STOCK  Authorized
Stock  At inception, the Company has authorized 100,000,000 common shares
and 100,000,000 preferred shares, both with a par value of $0.001 per share.
 Each common share entitles the holder to one vote, in person or proxy, on
any matter on which action of the stockholders of the corporation is sought.  Effective July 1, 2009, the Company increased the number of
authorized common shares to 2,000,000,000 shares, of which 1,900,000,000 shares
are designated as common stock par value $0.00001 per share, and 100,000,000
shares are designated as preferred stock, par value $0.001 per share.  Share Issuance  On November 18, 2008, the Company effected a 4 for 1 forward
split, of its common stock, under which each stockholder of record, received 4
new shares of the Corporations stock for every one share outstanding.  On June 19, 2009, the Company effected a 20 for 1 forward split,
of its common stock, under which each stockholder of record on July 10, 2009,
received 20 new shares of the Corporations stock for every one share
outstanding.  Since its inception, the Company has issued outstanding shares of
its common stock as follows, retroactively adjusted to give effect to the
cumulative 80 for 1 forward splits:  Price Per  Date Description Shares  Share  Amount             06/30/06 Stock issued for cash 80,000,000 $ 0.0000625 $    5,000   09/29/06 Stock issued for cash 160,000,000 0.000125 20,000 07/11/07 Stock issued for cash 244,000,000 0.00025 61,000 01/15/09 Stock issued for services 400,000  0.00005 20 03/09/09 Stock issued for services 1,000,000 0.00005 50  06/18/09 Stock issued for license 120,000,000 0.001 120,000  12/31/09     Cumulative Totals 605,400,000  $206,070   9    Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements December 31, 2009 (Unaudited)   NOTE 3
-   CAPITAL STOCK (continued)  In addition to the above shares, 56,000,000 shares are pending
cancellation.  These shares were issued and subsequently cancelled when the
merger with Ophthalmic International, Inc. was rescinded. However, the physical
certificate was lost and thus it is being disclosed separately in our share
capital.  The shares have legally been cancelled, but are still outstanding
until the physical certificate can be surrendered to our transfer agent.
 Management has placed a stop with our transfer agent and will not permit
these shares to be negotiated or reissued.  There are no preferred shares outstanding.  The Company has
no stock option plan, warrants or other dilutive securities.  NOTE 4 - PROVISION FOR INCOME TAXES  The Company recognizes the tax effects of transactions in the year
in which such transactions enter into the determination of net income,
regardless of when reported for tax purposes. Deferred taxes are provided in the
financial statements under ASC 718-740-20 to give effect to the resulting
temporary differences which may arise from differences in the bases of fixed
assets, depreciation methods, allowances, and start-up costs based on the income
taxes expected to be payable in future years.  Development stage deferred tax assets arising as a result of net
operating loss carryforwards have been offset completely by a valuation
allowance due to the uncertainty of their utilization in future periods.
Operating loss carryforwards generated during the period from May 30, 2006 (date
of inception) through December 31, 2009 of approximately $236,837 will begin to
expire in 2026. Accordingly, deferred tax assets of approximately $81,500 were
offset by the valuation allowance that increased by approximately $1,000 and
$8,500 during the three months ended December 31, 2009 and 2008,
respectively.  The Company follows the provisions of uncertain tax positions as
addressed in ASC 740-10-65-1. The Company recognized approximately no increase
in the liability for unrecognized tax benefits. The Company has no tax position at December 31, 2009 for which the
ultimate deductibility is highly certain but for which there is uncertainty
about the timing of such deductibility. The Company recognizes interest accrued
related to unrecognized tax benefits in interest expense and penalties in
operating expenses. No such interest or penalties were recognized during the
periods presented. The Company had no accruals for interest and penalties at
September 30, 2009 and 2008. The Companys utilization of any net operating loss
carry forward may be unlikely as a result of its intended development stage
activities.  NOTE 5 - DUE TO RELATED PARTY  As of December 31, 2009 and September 30, 2009, the Company was
obligated to a stockholder, for a non-interest bearing demand loan with a
balance of $21,414 and $9,388, respectively.  The Company plans to pay the
loan back as cash flows become available.  Interest has not been imputed on
these advances due to its immaterial impact on the financial statements.        10    Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements December 31, 2009 (Unaudited)    NOTE 6 - GOING CONCERN AND LIQUIDITY CONSIDERATIONS  The accompanying
financial statements have been prepared assuming that the Company will continue
as a going concern, which contemplates the realization of assets and the
liquidation of liabilities in the normal course of business.  As at
December 31, 2009, the Company has a loss from operations of $3,463, an
accumulated deficit of $236,837, and working capital deficiency of $30,767, and
has earned no revenues since inception.  The Company intends to fund
operations through equity financing arrangements, which may be insufficient to
fund its capital expenditures, working capital and other cash requirements for
the year ending September 30, 2010.  The ability of the
Company to emerge from the development stage is dependent upon, among other
things, obtaining additional financing to continue operations, and development
of its business plan.  In response to these
problems, management intends to raise additional funds through public or private
placement offerings.  These factors, among
others, raise substantial doubt about the Companys ability to continue as a
going concern.  The accompanying financial statements do not include any
adjustments that might result from the outcome of this uncertainty.  NOTE 7 - SUBSEQUENT EVENTS  The Company has evaluated subsequent events from the balance sheet
date through February 10, 2010 and determined there are no items to disclose.    11      ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS Forward-Looking Statements Except for historical information, this report contains
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Such
forward-looking statements involve risks and uncertainties, including, among
other things, statements regarding our business strategy, future revenues and
anticipated costs and expenses.  Such forward-looking statements include,
among others, those statements including the words expects, anticipates,
intends, believes and similar language.  Our actual results may differ
significantly from those projected in the forward-looking statements.
 Factors that might cause or contribute to such differences include, but
are not limited to, those discussed herein as well as in the Description of
Business  Risk Factors section in our Annual Report on Form 10-K for the year
ended September 30, 2009.  You should carefully review the risks described
in our Annual Report and in other documents we file from time to time with the
Securities and Exchange Commission.  You are cautioned not to place undue
reliance on the forward-looking statements, which speak only as of the date of
this report. We undertake no obligation to publicly release any revisions to the
forward-looking statements or reflect events or circumstances after the date of
this document. Although we believe that the expectations reflected in these
forward-looking statements are based on reasonable assumptions, there are a
number of risks and uncertainties that could cause actual results to differ
materially from such forward-looking statements. All references in this Form 10-Q to the Company, Cytta, we,
us, or our are to Cytta Corp. Results of
Operations  We
are a development stage corporation.  We have generated no revenues from
our business operations since inception (May 30, 2006) and have incurred
$236,837 in expenses through September 30, 2009. The
following table provides selected financial data about our company as of
December 31, 2009 and September 30, 2009, respectively. Balance
Sheet Data December
31, 2009 September
30, 2009 Cash
and cash equivalents $ 136 $ 136 Total
assets $ 136 $ 136 Total
liabilities $ 30,903 $ 27,440 Shareholders
equity (deficit) $ (30,767) $ (27,304)  Net
cash provided by financing activities since inception (May 30, 2006) through
December 31, 2009 was $107,414, being $86,000 raised from the sale of our common
stock and $21,414 from loans from a shareholder. Plan
of Operation On June 18th, 2009, the Company entered into a
Licensing Agreement with Lifespan, Inc.  Through a series of transactions
and business developments commencing in 2002, Lifespan had acquired the
expertise and licenses to manufacture, distribute and market various
technology-based internet access and computing products and services, consisting
of internet access devices, related software and hardware and a series of
medical peripherals designed and adapted to provide remote non-diagnostic
monitoring of  12      home based and remote patients.  Under the terms of the
Agreement with Cytta, Lifespan granted the Company the exclusive license to
manufacture, sell, distribute, operate, sub-license and market these internet
access devices, products and services in the United States.  The Company
plans to utilize the License to develop a model for the internet access devices
which can incorporate the numerous technology advances which are currently
available and is currently pursuing this avenue.   In exchange for the
license, Lifespan has received 120,000,000 shares of the Companys common stock,
plus a license fee equal to one half of one percent (.5%) of the net revenue
derived from the sale and use of the products and services. We have minimal operating costs and expenses at the present time
due to our limited business activities. However we anticipate significantly
increasing our activities as a result of the license acquisition.
 Accordingly, we will be required to raise significant capital over the
next twelve months, in connection with our license transactions.  We do not
currently engage in any product research and development however the Companys
license may cause us to engage in research and development in the foreseeable
future.  We have no present plans to purchase or sell any plant or
significant equipment although we may have to acquire some equipment related to
the license transaction.  We also have no immediate plans to add employees
although we may do so in the future as a result of the License acquisition. Liquidity and
Capital Resources  Our cash and cash equivalents balance as of December 31, 2009 was
$136. We are
a development stage company and currently have no operations.  We do
not have sufficient funds on hand to pursue our business objectives for the near
future or to commence operations without seeking additional funding. We
currently do not have a specific plan of how we will obtain such funding.  Loans to the Company  We have
been receiving loans from a shareholder of the company to pay general operating
costs.  As of December 31, 2009, we owed him $21,414.  The loan does
not incur interest or have any repayment terms.  We have
minimal operating costs and expenses at the present time due to our limited
business activities.  We will, however, be required to raise additional
capital over the next twelve months to meet our current administrative expenses
and to develop our operations. This financing may take the form of additional
sales of our equity or debt securities to, or loans from, stockholders, or from
our sole officer and director.  There is no assurance that additional
financing will be available from these or other sources, or, if available, that
it will be on terms favorable to us.  Going Concern  Our
auditors have included an explanatory paragraph in their report on our financial
statements relating to the uncertainty of our business as a going concern, due to our limited
operating history, our lack of historical profitability, and our limited funds.
We believe that we will be able to raise the required funds for operations and
to achieve our business plan.   13      Off-Balance Sheet Arrangements We have never entered into any off-balance sheet financing
arrangements and have not formed any special purpose entities.  We have not
guaranteed any debt or commitments of other entities or entered into any options
on non-financial assets. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. ITEM 4T. CONTROLS AND PROCEDURES Evaluation of Our Disclosure Controls Under the supervision and with the participation of our senior
management, including our chief executive officer and chief financial officer,
Stephen Spalding, we conducted an evaluation of the effectiveness of the design
and operation of our disclosure controls and procedures, as defined in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended
(the Exchange Act), as of the end of the period covered by this quarterly
report (the Evaluation Date). Based on this evaluation, our chief executive
officer and chief financial officer concluded as of the Evaluation Date that our
disclosure controls and procedures were effective such that the information
relating to us, required to be disclosed in our Securities and Exchange
Commission (SEC) reports (i) is recorded, processed, summarized and reported
within the time periods specified in SEC rules and forms, and (ii) is
accumulated and communicated to our management, including our chief executive
officer and chief financial officer, as appropriate to allow timely decisions
regarding required disclosure. Changes in Internal Control Over Financial Reporting There have been no changes in our internal control over financial
reporting that occurred during the quarter ended December 31, 2009 that have
materially affected or are reasonably likely to materially affect our internal
control over financial reporting. PART II  OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS In the ordinary course of our business, we may from time to time
become subject to routine litigation or administrative proceedings which are
incidental to our business. We are not a party to nor are we aware of any
existing, pending or threatened lawsuits or other legal actions involving
us. ITEM 1A. RISK FACTORS Not applicable. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS We did not issue any equity securities during the quarter ended
December 31, 2009. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None.  14      ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None. ITEM 5. OTHER INFORMATION Not applicable. ITEM 6. EXHIBITS The following exhibits are included as part of this report: Exhibit No. Description 31.1 / 31.2 Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive
and Financial Officer 32.1 / 32.2 Rule 1350 Certification of Principal Executive and Financial
Officer  15      SIGNATURES  Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.    CYTTA CORP.   Dated:  February 16, 2010 By:/s/Stephen Spalding Stephen
Spalding President, Principal Executive and Financial Officer    16